mynth
← DATABASE
03/2016100%

Glion Institute and les Roches acquired by Eurazeo

SWITZERLAND Education / Education Providers EV CHF 300–700M

Context

Eurazeo signed an agreement to acquire 100% of the capital of Glion Institute of Higher Education and Les Roches International School of Hotel Management from the US group Laureate Education. Eurazeo acts as the sole investor, providing the full equity requirement. The transaction is a corporate carve-out of two premium assets from Laureate's portfolio. The strategic plan focuses on maintaining the academic autonomy of the schools while accelerating their international development (particularly the recently opened campuses in London and the US) and digital programs. The deal is subject to customary closing conditions.

Glion Institute and les Roches, which reported an EBITDA margin of [members only] in 2015, is valued in this transaction at an EV/EBITDA multiple of 10x–18x, to compare with the average currently observed in the Retail & Consumer sector (11.8x in 2026).

-> Deep-dive in Retail & Consumer market trends

Target

Glion and Les Roches are two prestigious Swiss private schools specializing in hospitality and luxury management. Together, they enroll nearly 5,000 students (2,000 for Glion, 2,900 for Les Roches) across campuses in Switzerland, the UK, Spain, Jordan, China, and the US. They are consistently ranked among the top 3 hospitality schools worldwide and are accredited by the NEASC.

Ent. Value

CHF 300–700M

Equity Value

[members only]

Multiples

EV / Revenue

1x–3x

EV / EBITDA

10x–18x

EV / EBIT

[members only]

Historical Financials (CHF)

Year
Rev
EBITDA
EBIT
2015
CHF 100–200M
CHF 10–30M
[members only]
2014
CHF 100–200M
CHF 10–30M
[members only]

Other operations with Eurazeo

Other operations with Eurazeo
DateAcquirerTargetCountrySector
10/2026EURAZEOMIYA WATERSPAINWater
06/2026EURAZEOLAURALUFRANCEEquipment Rental
04/2026EURAZEONETCO GROUPFRANCEMaintenance
11/2025EURAZEOEXCELYAFRANCECRO / Clinical Trials
03/2025EURAZEOBIOLINE AGROSCIENCESFRANCESpecialized & Indoor Farming
02/2025EURAZEO / TURENNE CAPITAL / KURMA PARTNERSGERMITECFRANCEMedical Devices
11/2024EURAZEOEOWINFRANCEIT Services
04/2024EURAZEOERESFRANCEWealth & Asset Management
09/2023EURAZEO2B SERVICES & INNOVATIONSFRANCEWaste Management
11/2022EURAZEONEOXAMFRANCEFinancial Services / Banking

Similar deals in Education

Similar deals in Education
DateAcquirerTargetCountrySector
04/2018ABENEXEUREKA EDUCATIONFRANCEEducation Providers
04/2018TETHYS INVESTGALILEO GLOBAL EDUCATIONFRANCEEducation Providers
11/2017QUILVEST CAPITAL PARTNERSGROUPE EDHFRANCEEducation Providers
09/2017INVESTCORPIMPEROUNITED KINGDOMEdTech & Content
10/2016CATHAY CAPITAL / BPIFRANCEAD EDUCATIONFRANCEEducation Providers
09/2014PLATINA EQUITY SOLUTIONSGROUPE EDHFRANCEEducation Providers
04/2014JOHN WILEY & SONSCROSSKNOWLEDGEFRANCEEdTech & Content
03/2014CHARTERHOUSESKILLSOFTIRELANDEdTech & Content
10/2013SEVEN2OMNES EDUCATION (EX INSEEC)FRANCEEducation Providers
09/2013SIPAREXMEDIASCIENCEFRANCEEducational Equipment

REFERENCES

Valuation range: EV CHF 300–700M

Revenue range: CHF 100–200M

EBITDA range: CHF 10–30M

EV/Revenue range: 1x - 3x

EV/EBITDA range: 10x - 18x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Glion Institute and les Roches by Eurazeo are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Acquirer: eurazeo

FAQ

What transaction does this page cover?

This page covers Eurazeo’s acquisition of 100% of Glion Institute and les Roches, a Swiss company specialised in Education Providers, in 2016.

How was the acquisition of Glion Institute and les Roches by Eurazeo valued, and what multiples were paid?

mynth displays the transaction’s enterprise value within the CHF 300–700M band, its EV/EBITDA multiple within the 10x - 18x range, and its EV/revenue multiple within the 1x - 3x range. Exact figures are available to members.

What were Glion Institute and les Roches’s revenue and EBITDA at the time of the deal?

At the time of the transaction, Glion Institute and les Roches generated annual revenue estimated in the CHF 100–200M range and EBITDA in the CHF 10–30M bracket (FY 2015). Detailed financial figures are available to members.

How does the valuation of Glion Institute and les Roches compare to benchmarks in the Retail & Consumer sector?

With an estimated valuation multiple in the range of 10x - 18x in 2016, the transaction reflects historical valuation standards. By way of comparison, in 2026 companies in the Retail & Consumer sector are valued at a multiple of 11.8x EBITDA.

What sources support the information on this transaction?

The details of this transaction are sourced directly from the official corporate announcement published on the parties’ institutional website, ensuring primary-source verification of the closing and perimeter.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.